Back to the article

HealthRX.com · Printable titration log

Ozempic restart titration log

Track a restart week by week: the date and dose of each injection, stomach symptoms, fluids and glucose, against the label's actual dose steps, so the decision to step up rests on your own record.

Companion to “Ozempic Re-Titration After Stopping: How to Safely Restart Semaglutide” · healthrx.com/titration-ozempic/re-titration-after-stop · Facts checked 2026-10-18

Before the first restart dose

Date of your last Ozempic injection
Dose at that injection (mg)
Why the break happened
Restart dose your prescriber chose (mg)
Insulin or sulfonylurea doses now

The label's dose steps (Ozempic has no 1.7 mg step)[1]

In type 2 diabetes with chronic kidney disease, the label's maintenance dose is 1 mg.

StepWeekly doseWhen the label allows it
Start0.25 mgfor 4 weeks
Next0.5 mgafter 4 weeks on 0.25 mg
If more glucose control is needed1 mgafter at least 4 weeks on 0.5 mg
If still more is needed2 mg (maximum)after at least 4 weeks on 1 mg

Weekly restart record

WeekDateDose (mg)Nausea (none, mild, severe)Vomiting episodesDrinking normally?Glucose

Label points that bear on a restart

  • Most nausea, vomiting and diarrhea in the trials happened during dose escalation.[1]
  • Nausea in placebo-controlled trials: 15.8% on 0.5 mg and 20.3% on 1 mg, against 6.1% on placebo.[1]
  • With insulin or a sulfonylurea, low blood sugar is more likely; the label suggests considering lower doses of those when Ozempic is started.[1]
  • A missed dose can be taken within 5 days; after that, skip it and keep your usual day.[1]

Stop and call your prescriber for

  • Persistent or severe stomach pain, sometimes into the back, with or without vomiting.[1]
  • Nausea, vomiting or diarrhea that will not settle: fluid loss can cause kidney problems.[1]

Questions for the prescriber

  1. Do I restart at 0.25 mg or higher, and why?
  2. When will we decide whether to step up?
  3. Should my insulin or sulfonylurea dose change for the restart?
Sources for the facts on this sheet
  1. Novo Nordisk, via DailyMed. Ozempic (semaglutide) injection, for subcutaneous use: prescribing information and Medication Guide. Effective 2026-06-01. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79

This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.